Table 2: Escherichia coli MBC 10 µM at 1.0 × 10^3 CFU/mL.
- Measure
- MBC
- Value
- 10.0 µM
- Target
- Escherichia coli
- Assay
- Not reported by source
Biomolecules · 2025
Sequence evidence
RKWILKWLRTWKK
RKWILKWLRTWKK
Experimental observations
Table 2: Escherichia coli MBC 10 µM at 1.0 × 10^3 CFU/mL.
Table 2: Salmonella Typhimurium MBC 10 µM at 1.0 × 10^3 CFU/mL.
Table 2: Listeria monocytogenes MBC 10 µM at 1.0 × 10^3 CFU/mL.
Table 2: Staphylococcus aureus MBC 15 µM at 1.0 × 10^3 CFU/mL.
Table 2: Pseudomonas aeruginosa MBC 5 µM at 1.0 × 10^3 CFU/mL.
Table 2: Campylobacter jejuni MBC 80 µM at 1.0 × 10^3 CFU/mL.
Table 2: Monophasic Salmonella Typhimurium MBC 20 µM at 1.0 × 10^3 CFU/mL.
Table 2: Salmonella Napoli MBC 20 µM at 1.0 × 10^3 CFU/mL.
Table 3: Escherichia coli MBC 10.0 µM at 1.0 × 10^5 CFU/mL.
Table 3: Salmonella Typhimurium MBC 10.0 µM at 1.0 × 10^5 CFU/mL.
Table 3: Listeria monocytogenes MBC 10.0 µM at 1.0 × 10^5 CFU/mL.
Table 3: Staphylococcus aureus MBC 20.0 µM at 1.0 × 10^5 CFU/mL.
Table 3: Pseudomonas aeruginosa MBC 5.0 µM at 1.0 × 10^5 CFU/mL.
Table 5: Acinetobacter baumannii (CRAB) MIC 50 µM at 5 × 10^3 CFU/mL.
Table 5: Acinetobacter baumannii (CRAB) MBC 50 µM at 5 × 10^3 CFU/mL.
Table 5: Acinetobacter baumannii (CRAB) MIC 75 µM at 5 × 10^5 CFU/mL.
Table 5: Acinetobacter baumannii (CRAB) MBC >75 µM at 5 × 10^5 CFU/mL.
Table 5: Pseudomonas aeruginosa MIC 20 µM at 5 × 10^3 CFU/mL.
Table 5: Pseudomonas aeruginosa MBC 20 µM at 5 × 10^3 CFU/mL.
Table 5: Pseudomonas aeruginosa MIC 75 µM at 5 × 10^5 CFU/mL.
Table 5: Pseudomonas aeruginosa MBC >75 µM at 5 × 10^5 CFU/mL.
Table 5: Staphylococcus aureus (MRSA) MIC 50 µM at 5 × 10^3 CFU/mL.
Table 5: Staphylococcus aureus (MRSA) MBC 50 µM at 5 × 10^3 CFU/mL.
Table 5: Staphylococcus aureus (MRSA) MIC 50 µM at 5 × 10^5 CFU/mL.
Table 5: Staphylococcus aureus (MRSA) MBC 50 µM at 5 × 10^5 CFU/mL.
Figure 6 caption: RKW significantly inhibited biofilm production by S. aureus MRSA (ANOVA, p<0.01) at ½ and ¼ MIC.
Figure 6 caption: RKW significantly inhibited biofilm production by P. aeruginosa (ANOVA, p<0.05) at ½ and ¼ MIC.
Figure 7 caption and Section 3.6: RKW at 5, 10, 25 µM did not result in any significant effect on viability of BALB 3T3 cells.
Table 6: S. aureus ATCC 6538 at 100 µM, log R = 3.13, Not active.
Table 6: S. aureus ATCC 6538 at 50 µM, log R = 3.13, Not active.
Table 6: S. aureus ATCC 6538 at 20 µM, log R = 3.13, Not active.
Table 6: S. aureus ATCC 6538 at 10 µM, log R = 2.59, Not active.
Table 6: S. aureus ATCC 6538 at 5 µM, log R = 2.25, Not active.
Table 6: P. aeruginosa ATCC 15442 at 100 µM, log R > 5.25, Active.
Table 6: P. aeruginosa ATCC 15442 at 50 µM, log R > 5.25, Active.
Table 6: P. aeruginosa ATCC 15442 at 20 µM, log R > 5.25, Active.
Table 6: P. aeruginosa ATCC 15442 at 10 µM, log R > 5.25, Active.
Table 6: P. aeruginosa ATCC 15442 at 5 µM, log R > 5.25, Active.
Table 6: S. epidermidis ATCC 12228 at 100 µM, log R = 5.08, Active.
Table 6: S. epidermidis ATCC 12228 at 50 µM, log R = 5.08, Active.
Table 6: S. epidermidis ATCC 12228 at 20 µM, log R = 5.08, Active.
Table 6: S. epidermidis ATCC 12228 at 10 µM, log R = 4.90, Not active.
Table 6: S. epidermidis ATCC 12228 at 5 µM, log R = 4.71, Not active.
Table 6: C. albicans ATCC 10231 at 100 µM, log R = 4.16, Active.
Table 6: C. albicans ATCC 10231 at 50 µM, log R = 4.16, Active.
Table 6: C. albicans ATCC 10231 at 20 µM, log R = 4.16, Active.
Table 6: C. albicans ATCC 10231 at 10 µM, log R = 3.57, Not active.
Table 6: C. albicans ATCC 10231 at 5 µM, log R = 1.71, Not active.
Table 6: A. brasiliensis ATCC 16404 at 100 µM, log R = -0.09, Not active.
Table 6: A. brasiliensis ATCC 16404 at 50 µM, log R = -0.09, Not active.
Table 6: A. brasiliensis ATCC 16404 at 20 µM, log R = -0.09, Not active.
Table 6: A. brasiliensis ATCC 16404 at 10 µM, log R = -0.29, Not active.
Table 6: A. brasiliensis ATCC 16404 at 5 µM, log R = -0.28, Not active.
Local peptide labels such as P1, PEP1, or peptide 1 are grouped only within this paper and are not assumed to represent the same molecule across publications.